Whitepaper

Emergence of Novel Immune - Mediated Therapies

Market Research

Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to grow due to the rise in the prevalence of diseases, the increase in the adoption of combination therapies, the surge in the funding for new therapies, and the approval of innovative therapies.  Numerous opportunities within the realm of immune therapies exist, considering the increasing prevalence of several diseases. Moreover, there is a notable upswing in funding for developing innovative therapies and a rising trend in novel immunotherapies approval.

Key Takeaways

  • Immune therapies offer a great source of hope for patients but are typically expensive, substantially contributing to the rising healthcare costs.
  • Upcoming immune therapies will be the majority for oncology indications, followed by infectious and autoimmune indications.
  • Multiple clinical trials are actively underway, examining the potential synergistic benefits of combining immunotherapy with other treatment modalities.

To know more...



Related Topics

Technological  Advancements

Whitepapers

Future Trends and Technological Advances in Vaccine...

The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...

Trends to Watch 2024 - Media Broadcast Tech

Whitepapers

2024 Trends to Watch -TV & Video Technology

Media enterprises are steadily witnessing margin pressures attributed to the emergence of newer audience engagement touchpoints such as FAST channels,...

US OTT (SVOD) - The New Frontier

Whitepapers

US OTT (SVOD) - The New Frontier

The US OTT market has grown exponentially in recent years, driven by the increasing availability of high-speed internet and the proliferation of...

We bring comprehensive data driven insights to everyone, everywhere